¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Unit Dose Labeling Programs Misc"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dental unit
    Ä¡°úÁ¾ÇÕÄ¡·á´ë
  • district health unit
    Áö¿ªº¸°Ç´ÜÀ§
  • electrostatic unit
    Á¤Àü±â´ÜÀ§
  • electrosurgical unit
    Àü±â¼ö¼ú±â
  • epidermal-melanin unit
    Ç¥ÇǸá¶ó´Ñ´ÜÀ§
  • Hounsfield unit
    ÇϿÇʵå´ÜÀ§
  • infectious unit
    °¨¿°À¯¹ß´ÜÀ§
  • intensive care unit
    ÁßȯÀÚ½Ç, ÁýÁßÄ¡·á½Ç
  • international unit
    ±¹Á¦´ÜÀ§
  • motor unit
    ¿îµ¿´ÜÀ§
  • motor unit fraction
    ¿îµ¿´ÜÀ§ºÐȹ
  • maximum security unit
    ÃÖ´ë¾ÈÀüº´µ¿
  • pilosebaceous unit
    ÅÐÇÇÁö»ù´ÜÀ§
  • plaque-forming unit
    ÇöóÅ©Çü¼º´ÜÀ§
  • primary sampling unit
    ÀÏÂ÷ÃßÃâ´ÜÀ§
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • therapeutic dose
    Ä¡·á¿ë·®, Ä¡·á¼±·®
  • high-dose
    °í¿ë·®
  • dose-response relationship
    ¿ë·®¹ÝÀÀ°ü°è
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • coronary care unit
    ½ÉÀ嵿¸ÆÁúȯÁýÁßÄ¡·á½Ç
  • county health unit
    ±ºº¸°Ç´ÜÀ§
  • dental unit
    Ä¡°ú±â°è´ÜÀ§Ã¼
  • district health unit
    Áö¿ªº¸°Ç´ÜÀ§
  • unit discharge
    ´ÜÀ§¹ß»ç
  • electrostatic unit
    Á¤Àü´ÜÀ§
  • electrosurgical unit
    Àü±â¼ö¼ú±â
  • fertility unit
    °¡ÀÓ´ÜÀ§
  • focus forming unit
    ¹ÙÀÌ·¯½ºÆ÷Ä¿½ºÇü¼º´ÜÀ§
  • motor unit fraction
    ¿îµ¿´ÜÀ§ºÐȹ
  • hypothermia unit
    Àúü¿ÂÀåÄ¡
  • infectious unit
    °¨¿°À¯¹ß·®´ÜÀ§
  • intensive care unit
    ÁßȯÀÚ½Ç
  • intermittent traction unit
    °£Çæ°ßÀÎÀåÄ¡
  • maximum security unit
    ÃÖ´ë¾ÈÀüº´µ¿
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • angstrom unit
    ¿Ë½ºÆ®·Ò´ÜÀ§
  • antibody unit
    Ç×ü´ÜÀ§(ù÷ô÷Ó¤êÈ).
  • antibody unit
    Ç×ü´ÜÀ§(ù÷ô÷Ó¤êÈ).
  • antibody unit
    Ç×ü´ÜÀ§(ù÷ô÷Ó¤êÈ).
  • antitoxic unit
    Ç×µ¶¼Ò(¼º) ´ÜÀ§(ù÷Ô¸áÈàõ Ó¤êÈ).
  • antitoxin unit =Au
    Ç×µ¶¼Ò°¡(ù÷Ô¸áÈʤ).
  • glucose transport protein unit
    Æ÷µµ´ç ¿î¹Ý ´Ü¹é ´ÜÀ§(GLUT)
  • hemagglutinating unit
    Ç÷±¸ÀÀÁý ´ÜÀ§
  • hemoglobin unit
    Çì¸ð±Û·Îºó ´ÜÀ§.
  • hypothermia unit
    Àúü¿ÂÀåÄ¡.
  • immunizing unit
    ¸é¿ª´ÜÀ§(¡­Ó¤êÈ).
  • infectious unit
    °¨¿°À¯¹ß·®´ÜÀ§
  • intensive care unit =ICU
    ÁßȯÀÚ½Ç(ñìü´íºãø).
  • phage plaque-forming unit
    ÆÄÁö¿ë±Õ Çü¼º´ÜÀ§, ÆÄÁöÇöóÅ© Çü¼º´ÜÀ§
  • pilosebaceous unit
    Åб⸧»ù
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • antibody unit
    Ç×ü´ÜÀ§(ù÷ô÷Ó¤êÈ).
  • antibody unit
    Ç×ü´ÜÀ§(ù÷ô÷Ó¤êÈ).
  • antibody unit
    Ç×ü´ÜÀ§(ù÷ô÷Ó¤êÈ).
  • antigen unit
    Ç׿ø´ÜÀ§.
  • antitoxic unit
    Ç×µ¶¼Ò(¼º) ´ÜÀ§(ù÷Ô¸áÈàõ Ó¤êÈ).
  • antitoxin unit =Au
    Ç×µ¶¼Ò°¡(ù÷Ô¸áÈʤ).
  • atomic mass unit
    ¿øÀÚÁú·®´ÜÀ§
  • atomic unit
    ¿øÀÚ´ÜÀ§(¡­Ó¤êÈ).
  • burst-forming unit
    ¹ö½ºÆ®Çü¼º ´ÜÀ§
  • clinical unit
    ÀÓ»ó´ÜÀ§(¡­Ó¤êÈ).
  • coding unit
    ºÎȣ󸮴ÜÀ§.
  • colony forming unit
    Áý¶ôÇü¼º´ÜÀ§(ó¢Õªû¡à÷Ó¤êÈ)
  • colony forming unit (CFU)
    Áý¶ô¼ö, »ý±Õ¼ö, ¼¼Æ÷±º¼ö
  • colony-forming unit
    Áý¶ôÇü¼º ´ÜÀ§
  • complement unit
    º¸Ã¼´ÜÀ§(¡­Ó¤êÈ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • lethal dose
    Ä¡»ç·®(öÈÞÝÕá)
  • maximum permissible dose
    ÃÖ´ëÇã¿ë·®(õÌÓÞúÉé»Õá)
  • median effective dose
    Á¤Áß À¯È¿·®(ïáñéêóüùÕá)
  • median hemolytic dose
    Á¤Áß ¿ëÇü·®(ïáñééÁúìÕá)
  • median immunizing dose
    Á¤Áß ¸é¿ª·®(ïáñéØóæµÕá)
  • median infectious dose
    Á¤Áß °¨¿°·®(ïáñéÊïæøÕá)
  • median lethal dose
    Á¤Áß Ä¡»ç·®(ïáñéöÈÞÝÕá)
  • median paralysis dose
    Á¤Áß ¸¶ºñ·®(ïáñ騫ÝöÕá)
  • median tissue culture dose
    Á¤ÁßÁ¶Á÷¹è¾ç·®(ïáñéðÚòÄÛÆå×Õá)
  • median toxic dose
    Á¤Áß µ¶¼º·®(ïáñéÔ¸àõÕá)
  • minimum hemagglutinating dose
    ÃÖ¼ÒÇ÷±¸ÀÀÁý·®(õÌá³úìϹëêó¢Õá)
  • minimum hemolytic dose
    ÃÖ¼Ò¿ëÇ÷·®(õÌá³éÁúìÕá)
  • minbimum lethal dose
    ÃÖ¼ÒÄ¡»ç·®(õÌá³öÈÞÝÕá)
  • permissible dose
    Çã¿ë·®(úÉé»Õá)
  • priming dose
    ÀÏÂ÷󸮿뷮(ìéó­ô¥×âéÄÕá)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • curative dose
    ġȿ·®
  • depth dose
    ½ÉºÎ¼±·®
  • dose rate
    ¼±·®·ü
  • fatal dose
    Ä¡»ç·®
  • half lethal dose
    ¹ÝÄ¡»ç·®
  • LD = lethal dose
    Ä¡»ç·®
  • lethal dose [=LD]
    Ä¡»ç·®
  • maintenance dose
    À¯Áö¿ë·®
  • maximal acceptable dose
    ÃÖ´ëÇã¿ë¼±·®
  • maximum permissible dose [=MPD]
    ÃÖ´ëÇã¿ë(¼±)·®
  • median lethal dose
    50%Ä¡»ç·®, Æò±ÕÄ¡»ç·®
  • midbreast dose
    À¯¹æÁß¾ÓÁ¶»ç¼±·®
  • minimal effective dose
    ÃÖ¼ÒÀ¯È¿·®
  • permissible internal dose
    ³»ºÎÇã¿ë¼±·®
  • radiation absorbed dose
    ¶óµå, ¹æ»ç¼±Èí¼ö¼±·®
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HU heat unit; hemagglutinating unit; hemolytic unit; Hounsfield unit; human urine, human urinary; hydro...
TU thiouracil; thyroid uptake; Todd unit; toxin unit; transmission unit; transurethral; tuberculin unit...
AU according to custom [Lat. ad usum]; allergenic unit; ngstrom unit; antitoxin unit; arbitrary unit; A...
CCU cardiac care unit; Cherry-Crandall unit; coronary care unit; critical care unit
MU megaunit; mescaline unit; methyluric [acid]; Montevideo unit; motion unsharpness; motor unit; mouse ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ISEL In situ and labeling
Ki-67 LI Ki-67 labeling index
LI Labeling Index
LI Labeling Indices
LIs Labeling indices
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • operational unit
    ÀÛ¿ë ´ÜÀ§
  • pepsin unit
    Æé½Å ´ÜÀ§
    À§¾× ÁßÀÇ Æé½ÅÀ» Á¤·®ÇÏ´Â µ¥ ¾²ÀÌ´Â ´ÜÀ§.
  • peripheral resistance unit
    ¸»ÃÊ ÀúÇ× ´ÜÀ§
  • pilosebaceous unit
    ºÎ¼Ó ±â°ü
  • plaque forming unit
    ÇöóÅ© Çü¼º ´ÜÀ§
  • plating unit
    µµ±Ý±â
    Àü±â µµ±Ý½ÃŰ´Â ±â±¸.
  • portable X-ray unit
    À̵¿ X¼± ÀåÄ¡
  • pulse control unit
    ¸Æ¹Ú Á¶Àý ´ÜÀ§
  • radiation unit
    ¹æ»ç¼± ´ÜÀ§
  • resonance unit
    °ø¸í ´ÜÀ§
  • roentgen unit
    X¼± ´ÜÀ§, ·ÛÆ®°Õ ´ÜÀ§
  • self care unit
    ÀÚ°¡ °ü¸® Åõ¼®
    ½º½º·Î Ç÷¾× Åõ¼®À» ÇÏ´Â ½Ã½ºÅÛ.
  • sensory unit
    °¨°¢ ´ÜÀ§, Áö°¢ ´ÜÀ§
    1. 1°³ÀÇ ±¸½É¼º ¼¶À¯°¡ ºÐÆ÷Çϰí ÀÖ´Â ¿µ¿ª. 2. ´ÜÀÏ Áö°¢ ½Å°æ°è¿¡ ÀÇÇØ Áö¹èµÇ°í ÀÖ´Â Áö°¢±â.
  • skin test unit
    ÇǺΠ°Ë»ç ´ÜÀ§
  • skin unit
    ÇǺΠ´ÜÀ§
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
air dose The radiation dose, expressed in roentgens, delivered at a point in free air.
Synonym: air dose.
(05 Mar 2000)
bone marrow dose The cumulative dose to the blood-forming organ from therapeutic or nuclear fallout irradiation; the presumed leukemogenic dose.
(05 Mar 2000)
booster dose A dose given at some time after an initial dose to enhance the effect, said usually of antigens for the production of antibodies.
(05 Mar 2000)
breast dose in mammography <radiology> 180 mrad / view -- mid-breast dose, guideline: less than 1 rad for 2-view exam
(12 Dec 1998)
maintenance dose In chemotherapy, systematic dosage at a level that maintains protection against exacerbation.
(05 Mar 2000)
genetically significant dose <physics, radiobiology> The genetically significant dose is that which, if received by every member of the population, would be expected to produce the same genetic injury to the population as do the actual doses received by the individuals irradiated.
Thus, the genetically significant dose is the dose equivalent to the gonads weighted for the age and sex distribution in those members of the irradiated population expected to have offspring. The genetically significant dose is expressed in sieverts (or rem).
Acronym: GSD
(06 Aug 1998)
maximal dose <pharmacology> The largest amount of a drug or physical procedure that an adult can take with safety.
(05 Mar 2000)
maximum permissible dose <radiobiology> Defined by the International Commission on Radiological Protection as the greatest dose of radiation which, in the light of present knowledge, is not expected to cause detectable bodily injury to a person at any time during his lifetime.
This dose has been reduced with each Commission report. The MPD is given in terms of acute or chronic exposure of the whole body or of organs, systems, or regions of the body, and differs for persons who are occupationally exposed versus the public at large.
(05 Mar 2000)
median effective dose The dose that produces the desired effect; when followed by a subscript (generally "ED50"), it denotes the dose having such an effect on a certain percentage (e.g., 50%) of the test animals; ED50 is the median effective dose, in radiation protection, the sum of the equivalent doses in all tissues and organs of the body weighted for tissue effects of radiation. The unit of effective dose is the sievert (Sv), epilation dose, the minimum amount of radiation sufficient to produce hair loss, usually in 10 to 14 days.
(05 Mar 2000)
gonadal dose The exposure dose to the male or female gonad, usually from incidental secondary radiation in diagnostic or therapeutic irradiation, or from whole-body irradiation.
Synonym: gonadal dose.
(05 Mar 2000)
gonad dose The exposure dose to the male or female gonad, usually from incidental secondary radiation in diagnostic or therapeutic irradiation, or from whole-body irradiation.
Synonym: gonadal dose.
(05 Mar 2000)
minimal dose <pharmacology> The smallest amount of a drug or physical procedure that will produce a desired physiologic effect in an adult.
(05 Mar 2000)
minimal infecting dose <microbiology> The smallest quantity of infectious material regularly producing infection; usually expressed as I.D.50, the quantity causing infection in 50% of a suitable series of animals or cells (cell cultures).
(05 Mar 2000)
minimal lethal dose <pharmacology> The minimal dose of a toxic substance or infectious agent that is lethal, as assayed in various experimental animals (e.g., the least amount of diphtheria toxin that, on an average, kills a 250-g guinea pig within 96 hours after subcutaneous inoculation).
When followed by a subscript (generally "MLD50"), denotes the minimal dose that is lethal to a certain percentage (e.g., 50%) of animals so assayed, LD05.
See: lethal dose.
(05 Mar 2000)
minimal reacting dose The minimal dose of a toxic substance causing a reaction, as manifested in the skin of a series of susceptible test animals; the assay is based on the development of a characteristic, minimal but definite, "standard," focal inflammation (congestion and oedema, induration, degenerative changes, and desquamation of epidermal cells).
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • kitchen unit
    ºÎ¾ý ¼³ºñ ÀϽÀ(Çϼö´ë,Á¶¸®´ë,ÂùÀå µî)
  • message unit
    (ÀüÈ­ ¿ä±Ý °è»êÀÇ) ÅëÈ­´ÜÀ§;ÅëÈ­µµ
  • microprocessing unit
    ÃʼÒÇü ¿¬»ê ó¸® ÀåÄ¡
  • mobile unit
    ÅÚ·¹ºñÀü Ä«¸Þ¶ó Á¶Á¤ ¸ð´ÏÅÍ ÀåÄ¡;¼Û½Å ÀåÄ¡¸¦ ºñÄ¡ÇÑ ´ëÇü Æ®·°
  • neighborhood unit
    (¿µ)±Ù¸° ÁÖÅÃÁö±¸(Àα¸ 1¸¸¸í Á¤µµÀÇ µµ½Ã °èȹ´ÜÀ§)
  • panzer unit
    ±â°èÈ­ ºÎ´ë;±â°© »ç´Ü
  • peripheral device(unit)
    ÁÖº¯ÀåÄ¡
  • power unit
    ³»¿¬ ±â°ü
  • price per unit
    (»óǰÀÇ) ÇÒÀÎ ÀüÀÇ ´Ü°¡;(īŻ·Î±× µî¿¡ ³ª¿Í ÀÖ´Â) ÆÇ¸Å Èñ¸Á °¡°Ý
  • relay mobile (unit)
    (¹æ¼Û¿ë)Áß°èÂ÷
  • sink unit
    ºÎ¾ý ¼³ºñ(¼öä,ÂùÀå,Á¶¸®´ë)
  • synchro unit
    µ¿±â Àüµ¿±âÀÇ ÀÏÁ¾
  • tail unit
    ¹ÌÀÍ
  • unit
    ÇѰ³;(±¸¼º)´ÜÀ§;ÇÑ»ç¶÷
  • unit character
    (MendelÀÇ ¹ýÄ¢)´ÜÀÏ ÇüÁú
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á